Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.65 |
| ▸ | TTR | P02766 | 3/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.51 |
| ▸ | ESR1 | P03372 | 4/20 | 0.46 |
| ▸ | TUBB4A | P04350 | 3/20 | 0.46 |
| ▸ | TUBB | P07437 | 3/20 | 0.46 |
| ▸ | TUBA3C | P0DPH7 | 3/20 | 0.46 |
| ▸ | TUBA1B | P68363 | 3/20 | 0.46 |
| ▸ | TUBA4A | P68366 | 3/20 | 0.46 |
| ▸ | TUBB4B | P68371 | 3/20 | 0.46 |
| ▸ | TUBB3 | Q13509 | 3/20 | 0.46 |
| ▸ | TUBB2A | Q13885 | 3/20 | 0.46 |
| ▸ | TUBB8 | Q3ZCM7 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20786804 | 0.92 | TTR (0.79) | KMT2ATTRKDM4EMEN1MAPT | |
| SCHEMBL19331479 | 0.85 | PTGS2 (0.57) | KMT2ATTRKDM4EMEN1MAPT | |
| SCHEMBL20581523 | 0.85 | KMT2A (0.68) | KMT2ATTRKDM4EMEN1MAPT | |
| SCHEMBL22141261 | 0.83 | TTR (0.60) | KMT2ATTRKDM4EMEN1MAPT | |
| SCHEMBL28377202 | 0.83 | TTR (0.60) | KMT2ATTRKDM4EMEN1MAPT | |
| SCHEMBL20581562 | 0.82 | KMT2A (0.64) | KMT2ATTRKDM4EMEN1MAPT | |
| SCHEMBL19976209 | 0.82 | KMT2A (0.59) | KMT2ATTRKDM4EMEN1MAPT | |
| SCHEMBL21819739 | 0.82 | TTR (0.69) | KMT2ATTRKDM4EMEN1MAPT | |
| SCHEMBL28462778 | 0.81 | KMT2A (0.82) | KMT2ATTRKDM4EMEN1MAPT | |
| SCHEMBL19039763 | 0.80 | KMT2A (0.56) | KMT2ATTRKDM4EMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10851042-B2 | Solubization of resveratrol glycolate and tartrate derivatives | ELC MANAGEMENT LLC (US) | 2020-12-01 | — | — | US | disclosed |
| US-20200299223-A1 | SOLUBIZATION OF RESVERATROL GLYCOLATE AND TARTRATE DERIVATIVES | ELC MANAGEMENT LLC | 2020-09-24 | — | — | US | disclosed |
| US-10717698-B2 | Resveratrol glycolate and tartrate derivatives and synthetic methods therefor | ELC MANAGEMENT LLC (US) | 2020-07-21 | — | — | US | disclosed |
| US-10662140-B2 | Method for skin-whitening using composition containing resveratryl triglycolate | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2020-05-26 | — | — | US | disclosed |
| US-20190071386-A1 | RESVERATROL GLYCOLATE AND TARTRATE DERIVATIVES AND SYNTHETIC METHODS THEREFOR | ELC MAN LLC (US) | 2019-03-07 | — | — | US | disclosed |
| WO-2017155875-A1 | RESVERATROL GLYCOLATE AND TARTRATE DERIVATIVES AND SYNTHETIC METHODS THEREFOR | ELC MANAGEMENT LLC (US) | 2017-09-14 | — | — | WO | disclosed |
| US-20170210694-A1 | METHOD FOR SKIN-WHITENING USING COMPOSITION CONTAINING RESVERATRYL TRIGLYCOLATE | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2017-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170210694-A1 | METHOD FOR SKIN-WHITENING USING COMPOSITION CONTAINING RESVERATRYL TRIGLYCOLATE | TYR, TH, MC1R | KMT2A 1648/4885TTR 253/4885KDM4E 3384/4885 |
| US-10662140-B2 | Method for skin-whitening using composition containing resveratryl triglycolate | TYR, TH, TREH | KMT2A 1541/4885TTR 139/4885KDM4E 3394/4885 |
| US-10851042-B2 | Solubization of resveratrol glycolate and tartrate derivatives | GRHPR, SORD, SUCNR1 | KMT2A 4392/4885TTR 28/4885KDM4E 3625/4885 |
| US-10717698-B2 | Resveratrol glycolate and tartrate derivatives and synthetic methods therefor | GRHPR, SUCNR1, TECR | KMT2A 3435/4885TTR 1497/4885KDM4E 2181/4885 |
| US-20200299223-A1 | SOLUBIZATION OF RESVERATROL GLYCOLATE AND TARTRATE DERIVATIVES | SORD, GRHPR, SUCNR1 | KMT2A 4461/4885TTR 65/4885KDM4E 4086/4885 |
| US-20190071386-A1 | RESVERATROL GLYCOLATE AND TARTRATE DERIVATIVES AND SYNTHETIC METHODS THEREFOR | GRHPR, HMGCR, SUCNR1 | KMT2A 2703/4885TTR 1350/4885KDM4E 2103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.